Physician profile
Raquel Torres
NPI 1225404171
$754.89
in general payments reported to CMS, 2019-2025
12 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.24 · 2022: $228 · 2023: $243 · 2024: $129 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $194.88 | 2022-2025 | Ozempic, Rybelsus, Tresiba |
| Boston Scientific Corporation | $109.26 | 2021-2022 | |
| Abbott Laboratories | $96.45 | 2022-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $85.48 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $68.24 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $46.66 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.64 | 2024-2025 | |
| Allergan, INC. | $32.98 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.13 | 2024 | Jardiance |
| Amgen INC. | $18.42 | 2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.68 | 2023 | Lifevest |
| Sobi, INC | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raquel Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.